The degree of loss of tumor suppressive functions, versus the context-dependent manifestation of gain-of-function (GOF) phenotypes, is highly variable between p53 mutants1–3, and the molecular mechanisms underlying these differences are unknown. Here, TP53 is linked to neoplasm.